TROY, Mich., June 9, 2010 (GLOBE NEWSWIRE) -- Viper Networks, Inc. (Pink Sheets:VPER), an emerging global telecommunication network operations and technical management company, announces today it has entered into an agreement with iNeedMD, Inc. to deploy a telemedicine network throughout Europe and the Middle East.
Viper will be providing telecommunications network operational aspects and technical management expertise throughout the deployment areas in Europe and the Middle East. Upon successful completion of this first phase, the agreement terms with iNeedMD, Inc. call for the additional deployment of the telemedicine network on a global basis.
About iNeedMD, Inc.
iNeedMD, Inc. (www.ineedmd.com) has developed an FDA approved Glove/Mitten Platform in which EKG electrodes are mounted in conformity with conventional standards, which generates a 12-lead diagnostic EKG (ECG). The system will enable patients and doctors to exchange live diagnostic information remotely, and allow continuous patient monitoring 24/7.
The glove/mitten is FDA approved for commercial use and is disposable after one use. The manufactured product will be ready for market shortly. The glove/mitten plugs into a miniaturized EKG algorithm and FDA approved transmission device.
The glove/mitten can be positioned on the patient's chest (as described in the package insert) by any health care professional with minimal training. There is no need for an EKG technician. With pre-printed and positioned electrodes on the glove/mitten, there is little likelihood of any incorrect connections, thus the Company's FDA approved Glove/Mitten Platform should flawlessly produce a properly recorded 12 lead EKG.
For additional information, please visit www.vipernetworks.com.
Except for the historical information contained herein, this press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from the results predicted and reported results should not be considered an indication of future performance. In addition, the factors discussed in the filings with the Securities and Exchange Commission, among other factors, could cause actual results to differ materially.